New York State Common Retirement Fund’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148K Hold
8,300
﹤0.01% 2495
2026
Q1
$75.5K Sell
8,300
-100
-1% -$1.26K ﹤0.01% 2652
2025
Q4
$115K Hold
8,400
﹤0.01% 2541
2025
Q3
$183K Hold
8,400
﹤0.01% 2331
2025
Q2
$100K Buy
+8,400
New +$106K ﹤0.01% 2655
2024
Q3
Sell
-193
Closed -$1.04K 3213
2024
Q2
$1.04K Sell
193
-600
-76% -$3.47K ﹤0.01% 3276
2024
Q1
$5.39K Buy
793
+18
+2% +$126 ﹤0.01% 3212
2023
Q4
$5.26K Sell
775
-63
-8% -$357 ﹤0.01% 3218
2023
Q3
$4.2K Sell
838
-13,662
-94% -$81.3K ﹤0.01% 3240
2023
Q2
$105K Buy
+14,500
New +$123K ﹤0.01% 2784
2022
Q3
Sell
-122
Closed -$2K 3301
2022
Q2
$2K Sell
122
-8,042
-99% -$82.2K ﹤0.01% 3290
2022
Q1
$85K Sell
8,164
-6,096
-43% -$55.5K ﹤0.01% 3062
2021
Q4
$160K Sell
14,260
-17
-0.1% -$255 ﹤0.01% 2951
2021
Q3
$253K Sell
14,277
-1,823
-11% -$34.2K ﹤0.01% 2816
2021
Q2
$307K Buy
+16,100
New +$311K ﹤0.01% 2835

Other funds holding CLPT

New York State Common Retirement Fund's CLPT Position: Q2 2026 in Review

New York State Common Retirement Fund held its ClearPoint Neuro (CLPT) position steady in Q2 2026 at 8,300 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #2495.

New York State Common Retirement Fund first reported a position in CLPT in Q2 2021 and has held it in 15 quarters since. The position peaked at $307K in Q2 2021. 29 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • New York State Common Retirement Fund held 8,300 shares of ClearPoint Neuro worth $148K as of Q2 2026.
  • New York State Common Retirement Fund left its ClearPoint Neuro share count unchanged in Q2 2026.
  • ClearPoint Neuro made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2495 holding.
  • New York State Common Retirement Fund first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 15 quarters since.
  • New York State Common Retirement Fund's ClearPoint Neuro position peaked at $307K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.